Novo Nordisk A/S

NVO 69.06
0.79 (1.2%)

Open: 68.06 High: 69.15 Low: 68.01

9 x 69.06 = 621.54
x $69.06 =

NYSE: NVO $159 Billion Large-Cap. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 26%. 1 Year Return 31%. 2020 YTD Return 19%. 1.5% dividend yield. 41 total dividend payments. Paid Biannually.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $49.24

The 52 Week Low is $49.24 set on Fri, Mar 20, 2020.

52WH $69.75

The 52 Week High is $69.75 set on Thu, Sep 17, 2020.

ATH $69.75

The All-Time High is $69.75 set on Thu, Sep 17, 2020.

52 Week Range

$49.24
$69.75
Mar 20, 2020
Sep 17, 2020

Earnings

5.07

Earnings Per Share

18.42

Price To Earnings Ratio


Q2 Earnings for Apr, May & Jun

Thu, Aug 6, 2020

Since Q2 Earnings Report

NVO 6.1%


Q3 Earnings for Jul, Aug & Sep

Fri, Oct 30, 2020

In 35 days

Dividends

1.50

Dividend Yield

1.04

Dividend Rate

Fri, Aug 14, 2020

Ex-Dividend Date

Tue, Aug 25, 2020

Dividend Payment Date

Biannual

Dividend Frequency

41

Dividend History

Profile

Novo Nordisk A/S trades on the NYSE. NVO's market cap is 158.8 Billion.

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 20% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Website

Related Channels

Account Channels

Track your portfolio and more.